Our publications in scientific and medical journals provide further details and audit of our scientific basis.

The following publications refer to our platform technology and present preclinical development data:

Murphy MP, Smith RAJ. Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations. Annu. Rev. Phamacol. Toxicol. 2007;47:629-56. Available online at http://pharmtox.annualreviews.org

Adlam VJ, Harrison JC, Porteous CM, et al. Targeting an antioxidant to mitochondria protects against cardiac ischemia-reperfusion injury. FASEB J 2005; 19:1088-95.

James AM, Cocheme HM, Smith RAJ, Murphy MP. Interactions of Mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. J Biol Chem 2005;280:21295-312.